Personalized cancer therapy – the key to the future

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.5, Iss.3, 2004-04, pp. : 225-228

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Personalized therapy and pharmacogenomics: future perspective

By Siest Géérard Marteau Jean-Brice Visvikis-Siest Sophie

Pharmacogenomics, Vol. 10, Iss. 6, 2009-06 ,pp. : 927-930

Future Medicine

Access to resources Recommend Favorite

Attitudes toward molecular testing for personalized cancer therapy

By Yusuf Rafeek A. Rogith Deevakar Hovick Shelly R. A. Peterson Susan K. Burton-Chase Allison M. Fellman Bryan M. Li Yisheng McKinney Carolyn Bernstam Elmer V. Meric-Bernstam Funda

Cancer, Vol. 121, Iss. 2, 2015-01 ,pp. : 243-250

Blackwell Publishing

Access to resources Recommend Favorite

Molecular Foundations for Personalized Therapy in Prostate Cancer

Current Drug Targets, Vol. 16, Iss. 2, 2015-02 ,pp. : 103-114

Bentham Science Publishers

Access to resources Recommend Favorite

Bladder Cancer: Molecular Determinants of Personalized Therapy

Current Drug Targets, Vol. 16, Iss. 2, 2015-02 ,pp. : 115-124

Bentham Science Publishers

Access to resources Recommend Favorite

Is vaccine therapy the future in cancer prevention?

By Frazer Ian

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 12, 2004-12 ,pp. : 2427-2434

Informa Healthcare

Access to resources Recommend Favorite